{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cell cycle", "gastric cancer", "molecular docking", "molecular dynamics", "pharmacophore"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27853354", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "28"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "11", "Day": "04"}], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2016"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of <i>Syzygium alternifolium</i> through molecular dynamics and pharmacophore-based screening.", "Pagination": {"StartPage": "3611", "EndPage": "3632", "MedlinePgn": "3611-3632"}, "Abstract": {"AbstractText": ["Continuous usage of synthetic chemotherapeutic drugs causes adverse effects, which prompted for the development of alternative therapeutics for gastric cancer from natural source. This study was carried out with a specific aim to screen gastroprotective compounds from the fruits of <i>Syzygium alternifolium</i> (Myrtaceae). Three flavonoids, namely, 1) 5-hydroxy-7,4'-dimethoxy-6,8-di-C-methylflavone, 2) kaempferol-3-O-<i>\u03b2</i>-d-glucopyranoside, and 3) kaempferol-3-O-<i>\u03b1</i>-l-rhamnopyranoside were isolated from the above medicinal plant by employing silica gel column chromatography and are characterized by NMR techniques. Antigastric cancer activity of these flavonoids was examined on AGS cell lines followed by cell cycle progression assay. In addition, pharmacophore-based screening and molecular dynamics of protein-ligand complex were carried out to identify potent scaffolds. The results showed that compounds 2 and 3 exhibited significant cytotoxic effect, whereas compound 1 showed moderate effect on AGS cells by inhibiting G2/M phase of cell cycle. Molecular docking analysis revealed that compound 2 has higher binding energies on human growth factor receptor-2 (HER2). The constructed pharmacophore models reveal that the compounds have more number of H-bond Acc/Don features which contribute to the inhibition of HER2 activity. By selecting these features, 34 hits were retrieved using the query compound 2. Molecular dynamic simulations (MDS) of protein-ligand complexes demonstrated conspicuous inhibition of HER2 as evidenced by dynamic trajectory analysis. Based on these results, the compound ZINC67903192 was identified as promising HER2 inhibitor against gastric cancer. The present work provides a basis for the discovery a new class of scaffolds from natural products for gastric carcinoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioinformatics Center, Division of Molecular Biology, Department of Zoology."}], "LastName": "Babu", "ForeName": "Tirumalasetty Muni Chandra", "Initials": "TM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Division, Department of Chemistry, Sri Venkateswara University, Tirupati, Andhra Pradesh."}], "LastName": "Rammohan", "ForeName": "Aluru", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioinformatics Center, Division of Molecular Biology, Department of Zoology."}], "LastName": "Baki", "ForeName": "Vijaya Bhaskar", "Initials": "VB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pathogen Biology Laboratory, Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India."}], "LastName": "Devi", "ForeName": "Savita", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Division, Department of Chemistry, Sri Venkateswara University, Tirupati, Andhra Pradesh."}], "LastName": "Gunasekar", "ForeName": "Duvvuru", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioinformatics Center, Division of Molecular Biology, Department of Zoology."}], "LastName": "Rajendra", "ForeName": "Wudayagiri", "Initials": "W"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ERBB2 protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, ErbB-2"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Chromatography, Gel"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemistry", "isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Fruit"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": ["chemistry", "isolation & purification", "metabolism", "pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Quantitative Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "Receptor, ErbB-2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Stomach Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Syzygium"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74\u2013108.", "ArticleIdList": ["15761078"]}, {"Citation": "Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354\u2013362.", "ArticleIdList": ["PMC4066052", "16489633"]}, {"Citation": "Arak A, Kull K. Factors influencing survival of patients after radical surgery for gastric cancer. A regional study of 406 patients over a 10-year period. Ann Oncol. 1994;33(8):913\u2013920.", "ArticleIdList": ["7818925"]}, {"Citation": "Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.", "ArticleIdList": ["16822992"]}, {"Citation": "Sikora K. Personalized cancer therapy-the key to the future. Pharmacogenomics. 2004;5(4):225\u2013228.", "ArticleIdList": ["15102537"]}, {"Citation": "Wang X, Yan SK, Dai WX, Liu XR, Zhang WD, Wang JJ. A metabolomics approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer. Int J Cancer. 2010;127(12):2841\u20132850.", "ArticleIdList": ["21351263"]}, {"Citation": "Bang YJ, van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotheraphy versus chemotheraphy alone for treatment of Her2-positive advanced gastric or gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trail. Lancet. 2010;376(9742):687\u2013697.", "ArticleIdList": ["20728210"]}, {"Citation": "Hynes NE, Ingham PW, Lim WA, Marshall CJ, Massagu\u00e9 J, Pawson T. Signalling change: signal transduction through the decades. Nat Rev Mol Cell Biol. 2013;14(6):393\u2013398.", "ArticleIdList": ["23636498"]}, {"Citation": "Cidon EU, Ellis SG, Inam Y, Adeleke S, Zarif S, Geldart T. Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers. 2013;5(1):64\u201391.", "ArticleIdList": ["PMC3730303", "24216699"]}, {"Citation": "Garcia F, Vizoso A, Martin L, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003;10(3):234\u2013241.", "ArticleIdList": ["12679307"]}, {"Citation": "Hayashi M, Inokuchi M, Takagi Y, et al. High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res. 2008;14(23):7843\u20137849.", "ArticleIdList": ["19047113"]}, {"Citation": "Burgess AW, Cho HS, Eigenbrot C, et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell. 2003;12(3):541\u2013552.", "ArticleIdList": ["14527402"]}, {"Citation": "Riquelme I, Saavedra K, Espinoza JA, et al. Molecular classification of gastric cancer: towards a pathway-driven targeted therapy. Oncotarget. 2015;6(28):24750\u201324779.", "ArticleIdList": ["PMC4694793", "26267324"]}, {"Citation": "Qi F, Li A, Inagaki Y, et al. Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer. Biosci Trends. 2010;4(6):297\u2013307.", "ArticleIdList": ["21248427"]}, {"Citation": "Kasetti RB, Nabi SA, Swapna S, Apparao C. Cinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifolium. Food Chem Toxicol. 2012;50(5):1425\u20131431.", "ArticleIdList": ["22342809"]}, {"Citation": "Devi S, Ansari SA, Vadivelu J, M\u00e9graud F, Tenguria S, Ahmed N. Helicobacter pylori antigen HP0986 (TieA) interacts with cultured gastric epithelial cells and induces IL8 secretion via NF-\u03baB mediated pathway. Helicobacter. 2014;19(1):26\u201336.", "ArticleIdList": ["24205801"]}, {"Citation": "Bai Y, Zhao F, Li Y, Wang L, Fang XJ, Wang CY. Ginkgo biloba extract induce cell apoptosis and G0/G1 cycle arrest in gastric cancer cells. Int J Clin Exp Med. 2015;8(11):20977\u201320982.", "ArticleIdList": ["PMC4723873", "26885028"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol. 2004;281:301\u2013311.", "ArticleIdList": ["15220539"]}, {"Citation": "MOE. 2011 . Molecular Operating Environment 2011.10. Chemical Computing Group Inc; Montreal, QC, Canada:"}, {"Citation": "Labute P. The generalized born/volume integral (GB/VI) implicit solvent model: estimation of free energy of hydration using London dispersion instead of atomic surface area. J Comput Chem. 2008;29(10):1693\u20131698.", "ArticleIdList": ["18307169"]}, {"Citation": "Yang S. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today. 2010;15(11\u201312):444\u2013450.", "ArticleIdList": ["20362693"]}, {"Citation": "Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1\u20133):43\u201356."}, {"Citation": "Lindorff-Larsen K, Piana S, Palmo K, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78(8):1950\u20131958.", "ArticleIdList": ["PMC2970904", "20408171"]}, {"Citation": "Sch\u00fcttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 8):1355\u20131363.", "ArticleIdList": ["15272157"]}, {"Citation": "Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J Phys Chem. 1987;91(24):6269\u20136271."}, {"Citation": "Berendsen HJC, Postma JPM, Van Gunsteren WF, Dinola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81(8):3684\u20133690."}, {"Citation": "Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52(12):7182\u20137190."}, {"Citation": "Lipinski CA, Lomdardo F, Dominy BW, Feeneey PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv Drug Deliv Rev. 1997;23(1\u20133):3\u201325.", "ArticleIdList": ["11259830"]}, {"Citation": "Aertgeerts K, Skene R, Yano J, et al. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem. 2011;286(21):18756\u201318765.", "ArticleIdList": ["PMC3099692", "21454582"]}, {"Citation": "Sali A, Blundell TL. Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779\u2013815.", "ArticleIdList": ["8254673"]}, {"Citation": "Kabsch W, Sander C. Dictionary of protein secondary structure pattern recognition hydrogen-bonded geometrical lectures. Biopolymers. 1983;22(12):2577\u20132637.", "ArticleIdList": ["6667333"]}, {"Citation": "Lobanow M, Bogatyrev NS, Galzitskaia OV. Radius of gyration is an indicator of compactness of protein structure. Mol Biol (Mosk) 2008;42(4):701\u2013706.", "ArticleIdList": ["18856071"]}, {"Citation": "Durham E, Dorr B, Woetzel N, Staritzbichler R, Meiler J. Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J Mol Model. 2009;15(9):1093\u20131108.", "ArticleIdList": ["PMC2712621", "19234730"]}, {"Citation": "Ishikawa T, Seto M, Banno H, et al. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo [3,2-d] pyrimidine scaffold. J Med Chem. 2011;54(23):8030\u20138050.", "ArticleIdList": ["22003817"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["27853354", "PMC5104305", "10.2147/DDDT.S111914", "dddt-10-3611"]}}], "PubmedBookArticle": []}